These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 15921180)

  • 1. Approach to adolescent polycystic ovary syndrome (PCOS) in the pediatric endocrine community in the U.S.A.
    Guttmann-Bauman I
    J Pediatr Endocrinol Metab; 2005 May; 18(5):499-506. PubMed ID: 15921180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trends in standard workup performed by pediatric subspecialists for the diagnosis of adolescent polycystic ovary syndrome.
    Powers SE; Uliassi NW; Sullivan SD; Tuchman LK; Mehra R; Gomez-Lobo V
    J Pediatr Adolesc Gynecol; 2015 Feb; 28(1):43-46. PubMed ID: 25555300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polycystic ovarian syndrome: marked differences between endocrinologists and gynaecologists in diagnosis and management.
    Cussons AJ; Stuckey BG; Walsh JP; Burke V; Norman RJ
    Clin Endocrinol (Oxf); 2005 Mar; 62(3):289-95. PubMed ID: 15730409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proposed criteria for the identification of polycystic ovary syndrome following menopause: An ancillary study of the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil).
    Gabrielli L; de Almeida Mda C; Aquino EM
    Maturitas; 2015 Jul; 81(3):398-405. PubMed ID: 26004079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Focus on BMI and subclinical hypothyroidism in adolescent girls first examined for amenorrhea or oligomenorrhea. The emerging role of polycystic ovary syndrome.
    Nezi M; Christopoulos P; Paltoglou G; Gryparis A; Bakoulas V; Deligeoroglou E; Creatsas G; Mastorakos G
    J Pediatr Endocrinol Metab; 2016 Jun; 29(6):693-702. PubMed ID: 27089404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. European survey of diagnosis and management of the polycystic ovary syndrome: results of the ESE PCOS Special Interest Group's Questionnaire.
    Conway G; Dewailly D; Diamanti-Kandarakis E; Escobar-Morreale HF; Franks S; Gambineri A; Kelestimur F; Macut D; Micic D; Pasquali R; Pfeifer M; Pignatelli D; Pugeat M; Yildiz B;
    Eur J Endocrinol; 2014 Oct; 171(4):489-98. PubMed ID: 25049203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The phenotype of hirsute women: a comparison of polycystic ovary syndrome and 21-hydroxylase-deficient nonclassic adrenal hyperplasia.
    Pall M; Azziz R; Beires J; Pignatelli D
    Fertil Steril; 2010 Jul; 94(2):684-9. PubMed ID: 19726039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polycystic ovary syndrome: a common but often unrecognized condition.
    Shannon M; Wang Y
    J Midwifery Womens Health; 2012; 57(3):221-30. PubMed ID: 22594862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. European survey of diagnosis and management of the polycystic ovary syndrome: full report on the ESE PCOS Special Interest Group's 2023 Questionnaire.
    Livadas S; Yildiz BO; Mastorakos G; Gambineri A; Pignatelli D; Giorgino F; Andersen MS; Obermayer-Pietsch B; Macut D;
    Eur J Endocrinol; 2024 Aug; 191(2):134-143. PubMed ID: 39099229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early endocrine, metabolic, and sonographic characteristics of polycystic ovary syndrome (PCOS): comparison between nonobese and obese adolescents.
    Silfen ME; Denburg MR; Manibo AM; Lobo RA; Jaffe R; Ferin M; Levine LS; Oberfield SE
    J Clin Endocrinol Metab; 2003 Oct; 88(10):4682-8. PubMed ID: 14557441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A simple screening approach for assessing community prevalence and phenotype of polycystic ovary syndrome in a semi-urban population in Sri Lanka.
    Kumarapeli V; Seneviratne Rde A; Wijeyaratne CN; Yapa RM; Dodampahala SH
    Am J Epidemiol; 2008 Aug; 168(3):321-8. PubMed ID: 18550559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An International Consortium Update: Pathophysiology, Diagnosis, and Treatment of Polycystic Ovarian Syndrome in Adolescence.
    Ibáñez L; Oberfield SE; Witchel S; Auchus RJ; Chang RJ; Codner E; Dabadghao P; Darendeliler F; Elbarbary NS; Gambineri A; Garcia Rudaz C; Hoeger KM; López-Bermejo A; Ong K; Peña AS; Reinehr T; Santoro N; Tena-Sempere M; Tao R; Yildiz BO; Alkhayyat H; Deeb A; Joel D; Horikawa R; de Zegher F; Lee PA
    Horm Res Paediatr; 2017; 88(6):371-395. PubMed ID: 29156452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metformin administration is more effective when non-obese patients with polycystic ovary syndrome show both hyperandrogenism and hyperinsulinemia.
    Genazzani AD; Lanzoni C; Ricchieri F; Baraldi E; Casarosa E; Jasonni VM
    Gynecol Endocrinol; 2007 Mar; 23(3):146-52. PubMed ID: 17454168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polycystic Ovary Syndrome among Obese Adolescents.
    Ybarra M; Franco RR; Cominato L; Sampaio RB; Sucena da Rocha SM; Damiani D
    Gynecol Endocrinol; 2018 Jan; 34(1):45-48. PubMed ID: 28758509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-classic adrenal hyperplasia due to the deficiency of 21-hydroxylase and its relation to polycystic ovarian syndrome.
    Pignatelli D
    Front Horm Res; 2013; 40():158-70. PubMed ID: 24002412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endocrine and metabolic characteristics in polycystic ovary syndrome.
    Glintborg D
    Dan Med J; 2016 Apr; 63(4):. PubMed ID: 27034186
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endocrine features of polycystic ovary syndrome in a random population sample of 14-16 year old adolescents.
    van Hooff MH; Voorhorst FJ; Kaptein MB; Hirasing RA; Koppenaal C; Schoemaker J
    Hum Reprod; 1999 Sep; 14(9):2223-9. PubMed ID: 10469684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin, leptin, IGF-I and insulin-dependent protein concentrations after insulin-sensitizing therapy in obese women with polycystic ovary syndrome.
    Kowalska I; Kinalski M; Straczkowski M; Wolczyski S; Kinalska I
    Eur J Endocrinol; 2001 May; 144(5):509-15. PubMed ID: 11331217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of metformin on insulin resistance and ovarian steroidogenesis in women with polycystic ovary syndrome.
    Unlühizarci K; Keleştimur F; Bayram F; Sahin Y; Tutuş A
    Clin Endocrinol (Oxf); 1999 Aug; 51(2):231-6. PubMed ID: 10468995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polycystic ovary syndrome: Pelvic MRI as alternative to pelvic ultrasound for the diagnosis in overweight and obese adolescent girls.
    Kayemba-Kay's S; Pambou A; Heron A; Benosman SM
    Int J Pediatr Adolesc Med; 2017 Dec; 4(4):147-152. PubMed ID: 30805521
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.